Loss of BRG1/BRM in human lung cancer cell lines and primary lung cancers: correlation with poor prognosis.

A role for the SWI/SNF complex in tumorigenesis based on its requirement for retinoblastoma induced growth arrest and p53-mediated transcription and the appearance of tumors in SWI/SNF-deficient mice. In addition, Western blot data have shown that the SWI/SNF ATPase subunits cell, BRG1 and BRM (BRG1/BRM), are lost in approximately 30% of human non-small lung cancer cell lines. To determine whether loss of expression of these proteins occurs in primary tumors, we examined their expression in 41 primary lung adenocarcinomas and 19 primary lung squamous carcinomas by immunohistochemistry. These analyses showed that 10% of tumors show a concomitant loss of BRG1 and BRM expression. Moreover, patients with BRG1/BRM-negative carcinomas, independent of stage, have a statistically significant decrease in survival compared with patients with BRG1/BRM. This report provides supportive evidence that BRG1 and BRM act as tumor suppressor proteins and implicates a role for their loss in the development of non-small cell lung cancers.

[1]  R. Kingston,et al.  Purification and characterization of mSin3A-containing Brg1 and hBrm chromatin remodeling complexes. , 2001, Genes & development.

[2]  F MURRAY,et al.  Diagnosis and treatment of lung cancer. , 1955, Geriatrics.

[3]  Matthew W. Strobeck,et al.  Compensation of BRG-1 Function by Brm , 2002, The Journal of Biological Chemistry.

[4]  E. Lees,et al.  Cyclin E Associates with BAF155 and BRG1, Components of the Mammalian SWI-SNF Complex, and Alters the Ability of BRG1 To Induce Growth Arrest , 1999, Molecular and Cellular Biology.

[5]  Weidong Wang,et al.  Characterization of SWI/SNF protein expression in human breast cancer cell lines and other malignancies , 2001, Journal of cellular physiology.

[6]  J. Minna,et al.  Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering. , 2000, Cancer research.

[7]  Alexander Kinev,et al.  BRCA1 Is Associated with a Human SWI/SNF-Related Complex Linking Chromatin Remodeling to Breast Cancer , 2000, Cell.

[8]  Andrew W. Murray,et al.  The Cell Cycle , 1989 .

[9]  Matthew W. Strobeck,et al.  BRG-1 is required for RB-mediated cell cycle arrest. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[10]  P. Brown,et al.  Whole-genome expression analysis of snf/swi mutants of Saccharomyces cerevisiae. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[11]  M. Carlson,et al.  Functional interdependence of the yeast SNF2, SNF5, and SNF6 proteins in transcriptional activation. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[12]  E. Salmon,et al.  The human SWI/SNF-B chromatin-remodeling complex is related to yeast rsc and localizes at kinetochores of mitotic chromosomes. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[13]  T. Mizutani,et al.  Identification of SWI·SNF Complex Subunit BAF60a as a Determinant of the Transactivation Potential of Fos/Jun Dimers* , 2001, The Journal of Biological Chemistry.

[14]  Matthew W. Strobeck,et al.  Concomitant down-regulation of BRM and BRG1 in human tumor cell lines: differential effects on RB-mediated growth arrest vs CD44 expression. , 2002 .

[15]  B. Weissman,et al.  The BRG-1 Subunit of the SWI/SNF Complex Regulates CD44 Expression* , 2001, The Journal of Biological Chemistry.

[16]  M. Yaniv,et al.  The murine SNF5/INI1 chromatin remodeling factor is essential for embryonic development and tumor suppression , 2000, EMBO reports.

[17]  J. Choe,et al.  SWI/SNF Complex Interacts with Tumor Suppressor p53 and Is Necessary for the Activation of p53-mediated Transcription* , 2002, The Journal of Biological Chemistry.

[18]  C. Roberts,et al.  Haploinsufficiency of Snf5 (integrase interactor 1) predisposes to malignant rhabdoid tumors in mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[19]  F Randazzo,et al.  A Brg1 null mutation in the mouse reveals functional differences among mammalian SWI/SNF complexes. , 2000, Molecular cell.

[20]  M. Yaniv,et al.  Chromatin modifiers and tumor suppression. , 2001, Biochimica et biophysica acta.

[21]  M. Yaniv,et al.  When the SWI/SNF complex remodels … the cell cycle , 2001, Oncogene.

[22]  D. Teng,et al.  BRG1, a component of the SWI-SNF complex, is mutated in multiple human tumor cell lines. , 2000, Cancer research.

[23]  A. Imbalzano,et al.  Mammalian SWI/SNF complexes promote MyoD-mediated muscle differentiation , 2001, Nature Genetics.

[24]  M. Yaniv,et al.  Altered control of cellular proliferation in the absence of mammalian brahma (SNF2α) , 1998, The EMBO journal.

[25]  Olivier Delattre,et al.  Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer , 1998, Nature.

[26]  R GEISSENDORFER,et al.  [Diagnosis and treatment of lung cancer]. , 1951, Strahlentherapie.

[27]  H Clevers,et al.  The chromatin remodelling factor Brg‐1 interacts with β‐catenin to promote target gene activation , 2001, The EMBO journal.

[28]  L. Pillus,et al.  Modifying chromatin and concepts of cancer. , 1999, Current opinion in genetics & development.

[29]  Duanduan Ma,et al.  Exit from G1 and S Phase of the Cell Cycle Is Regulated by Repressor Complexes Containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF , 2000, Cell.